Recently, a specific dysfunction of the TGF-β1 signaling pathway has been demonstrated in AD patients [30, 68] with a reduced expression of TGF-β type II receptor in neurons in an early phase of the disease. Here, TGFB1 is linked to Alzheimer disease.